Diana Hristova

Diana Hristova

Auto-generated profile, based on publicly available information

Diana Hristova

University Obstetrics and Gynecology Hospital “Maichin dom”, Bulgaria

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2022 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
DHDiana Hristova
Diana Hristova
GKGeorgi Kirilov
Georgi Kirilov
Background: Problems with hormonal changes and the related variations in bone turnover in adolescents with polycystic ovarian syndrome (PCOS) have been of interest in terms of providing these patients with an opportunity to receive a prophylactic and precision-based treatment aiming to prevent early onset of osteoporosis. Materials and methods: Prospective comparative clinical trial—‘case-control’ type in Bulgarian populace of 36 female patients with PCOS and 42 healthy controls aged 12 to 18. The study protocol included a general section of anthropometric patient data, clinical section–including general and Ob/Gyn Medical History, ultrasound exam of the lesser pelvis and a lab section examining the serum levels of Follicle-stimulating hormone (FSH), Luteinizing hormone (LH), estradiol, Anti-Müllerian hormone (AMH) and bone turnover markers–osteocalcin and β-CrossLaps (bCTX), as well as Vitamin D. Results: A statistically significant high serum levels of the gonadotropic hormones were observed (LH — p < 0.001 и FSH — p = 0.017), AMH (p < 0.001) in patients with PCOS compared to the controls, while the estradiol (p = 0.043) and osteocalcin (p < 0.001) levels displayed a statistically significant lower values in patients with PCOS compared to the control group. AMH can be utilized as a surrogate marker for diagnosing patients with PCOS where the marker shows sensitivity — 94% and specificity — 69% with threshold value (cut-off) at ≥5.95 ng/mL (area under the curve 0.854, p < 0.001). Significant variance in Vitamin D serum levels between the two groups was not detected. Conclusion: Despite the hormonal characteristic of normogonadotropic normogonadism in adolescent patients with PCOS, the significantly lower values of osteocalcin demonstrated suppressed bone metabolism–bone formation, in particular–compared to the healthy controls, which can be interpreted as increased risk of insufficient bone accretion and risk of early onset of osteoporosis later in life.

9 May 2024 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
VSVictoria Spasova
Victoria Spasova
LKLiliya Koleva
Liliya Koleva
SPSofia Operative Gynecology Clinic Umbalsm N. I. Pirogov
Sofia Operative Gynecology Clinic Umbalsm N. I. Pirogov
SSSvetlana Yasenova Shumarova
Svetlana Yasenova Shumarova
DHDiana Hristova
Diana Hristova
VKVesela Karamisheva
Vesela Karamisheva
Purpose: This case study refers to a case of complete androgen insensitivity syndrome, which presented with amenorrhea back in the past. Case: After conformation of the diagnosis, parents decided not to reveal the condition’s specifics to the patient. At the age of 34 years, she attended our hospital with abdominal swelling, and the following CT scan showed an abdominal mass arising from the ovary of 13 cm x 14 cm size. A laparotomy was done, and a mixture of solid and cystic mass of 20 cm in diameter was found and removed with the ovary. Histopathology of the tumor showed features of testicular seminoma. Conclusion: The aim of this case report is to outline the difficulties in choosing whether and when to do the gonadectomy and whether and how to explain the condition to the patient.

22 May 2025 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
DHDiana Hristova
Diana Hristova
IKIvan Kostov
Ivan Kostov
RTRadko Tocev
Radko Tocev
TPTanya Petkova
Tanya Petkova
IIIbryam Ibryam
Ibryam Ibryam
Ovarian tumors in children before puberty are rare and usually non-malignant. Granulosa cell tumors are rare sex cord-stromal tumors, accounting for 5% of all ovarian tumors and occur mainly in premenarchal girls and in women younger than 30 years. The diagnosis is based on the presence of precocious puberty, advanced bone age, palpable abdominal mass, nonspecific abdominal pain and abdominal swelling, vaginal discharge. In adolescent, it manifests with signs of menstrual irregularity and virilization. This is a case report of a 5-year-old Bulgarian patient with clinical and paraclinical findings of peripheral precocious puberty who underwent unilateral salpingo-oophorectomy after US and MRI was performed. From the performed imaging studies, Juvenile granulosa cell tumors was suspected. Histological findings confirmed the primary diagnosis – Granulosa cell tumor of juvenile type and TMN staging was: pT1a. It was decided not to perform adjuvant chemotherapy in view of the stage of the tumor process according to existing algorithms and the decision of the oncology committee. Generally, the prognosis is good. The most important prognostic factor associated with a higher risk of relapse is the stage of disease. Prolonged surveillance is essential in the described case because the disease tends to recur years after the initial diagnosis.

15 April 2025 in Journal of IMAB – Annual Proceeding (Scientific Papers)
Verified
Journal Article
Closed access
DHDiana Hristova
Diana Hristova
RTRadko Tocev
Radko Tocev
KNKrassimir Neykov
Krassimir Neykov
IIIbryam Ibryam
Ibryam Ibryam
SSSergei Slavov
Sergei Slavov
SSSmail Smail
Smail Smail
Complete Androgen Insensitivity Syndrome (CAIS) is a rare genetic Disorder of Sex Development linked to the X chromosome. It occurs due to mutations—either from mother inheritance or arising spontaneously—in the androgen receptor (AR) gene, located in the Xq11-q12 region. Individuals with CAIS have a 46, XY karyotype, meaning they are genetically male. However, due to a complete inability of their body's tissues to respond to androgens, they develop female external genitalia. Internally, they have fully formed but undescended testes and their bodies do not develop male reproductive structures. Diagnosis typically involves genetic testing, hormone analysis, and imaging to assess the presence of testes. This is a case report of a 15-year-old female-looking Bulgarian patient with primary amenorrhea who underwent prophylactic gonadectomy after ultrasound examination and MRI was performed. From the performed imaging studies, Sertoli cell adenoma was suspected. Histological findings were rudimentary testicles with the presence of paratesticular cysts (more prominent on the left). Rudimentary Fallopian tubes were also present. The patient's karyotype was 46, XY without any evidence of aberrations. A precise algorithm should be established for diagnosis, treatment and prevention for patients with CAIS, in order to improve the quality of life and prognosis. The key, in our opinion, is the multidisciplinary approach and the creation of specialized centers for children with rare genetic disorders.

30 October 2022 in Proceedings of the Bulgarian Academy of Sciences
Verified
Journal Article
Closed access
PDF file
DHDiana Hristova
Diana Hristova
MSMilko Sirakov
Milko Sirakov
A prospective study was conducted including 67 girls with secondary amenorrhoea (excluding cases with PCOS, medical disorders and steroid therapy) and 38 healthy controls. The following indicators were compared between the two groups: serum levels of LH, FSH, estradiol, Ca, P and vitamin D, z- scores for bone mineral density, osteocalcin and β-CrossLaps, and prevalence of vitamin D deficiency. The group with secondary amenorrhoea was additionally subdivided according to the main cause – alimentary deficiency, excessive physical exercise and stress-induced. LH, FSH and estradiol levels were compared between the three subgroups. Ca, P and vitamin D levels in the studied and the control groups were not significantly different. The following indicators were significantly lower in the studied group compared to the control one: prolactin (291.74 mIU/ml and 336.24 mIU/ml), estradiol (322.43 pmol/ml and 475.45 pmol/ml) and LH (3.79 IU/L and 4.99 IU/L) levels, LH/FSH ratio (0.55 and 0.96) and z-score (−0.48 and 0.47). FSH was significantly higher in the studied group (6.90 IU/L) compared to the control one (5.44 IU/L). The serum levels of LH and estradiol were significantly lower in the subgroup with secondary stress-induced amenorrhoea (1.73 IU/L and 220.60 pmol/ml) compared to the subgroups with amenorrhoea due to alimentary deficiency (4.68 IU/L and 394.68 pmol/ml) or extreme physical exercise (3.74 IU/L and 323.91 pmol/ml). In girls with secondary amenorrhea, the levels of osteocalcin were significantly lower compared to the ones in the control group (26.41 and 30.99 ng/ml) while β-CrossLaps levels were similar (0.34 and 0.98 ng/mL). High prevalence of vitamin D deficiency was observed in both the patients with secondary amenorrhoea (71.6%) and the control group (65.8%). Significant changes in hormone levels and bone health were observed in Bulgarian adolescent girls with secondary amenorrhoea as well as high prevalence of vitamin D deficiency in both the studied and the control groups. Early diagnosis and timely interventions are needed to improve bone health in adolescents with secondary amenorrhoea.

1 December 2025 in Acta Medica Bulgarica
Verified
Journal Article
Open access
PDF file
DHD. Hristova
D. Hristova
III. Ibryam
I. Ibryam
SHS. Hitrova-Nikolova
S. Hitrova-Nikolova
RTR. Tocev
R. Tocev
IKI. Kostov
I. Kostov
Endometriosis is an estrogen-dependent chronic inflammatory disease characterized by the proliferation of endometrial glandular tissue and stroma outside the uterine cavity. It is estimated that 4 to 17% of adolescent girls have the same form of endometriosis, and it is particularly common among those with dysmenorrhea who respond poorly to analgesics or estroprogestins. For those suffering from recurrent and chronic pelvic pain, the percentage rises to 25-38%. Possible explanations for the pathogenesis of endometriosis are: coelomic metaplasia, embryonic Müllerian rests, iatrogenic implantation, vascular and lymphatic metastasis, the genetic theory, and endometrial stem/progenitor cells that represent different hypotheses besides Sampson’s theory, the classic retrograde menstruation, which is the most widely accepted theory to explain the ectopic implantation of endometrium. According to the ESHRE guidelines, suggestive manifestations for endometriosis include early menarche, severe dysmenorrhea, dyspareunia, abnormal uterine bleeding, midcycle or acyclic pain, resistance to empiric medical treatment, and gastrointestinal and genitourinary symptoms. Known risk factors for developing endometriosis include: genetic predisposition; epigenetic variables – prematurity, bottle feeding, exposure to some pollutants with estrogenic activity; dysregulation of the immune and inflammatory response, as well as obstructive anomalies of the reproductive tract. Diagnosis is made by accurate anamnesis – personal and family history, gynecological examination and ultrasonographic evaluation (transabdominal and transvaginal ultrasound). Magnetic resonance can be useful to detect obstructive reproductive tract anomalies and to identify and characterize endometriotic lesions that are difficult to locate by ultrasound. A multidisciplinary diagnostic approach should be considered for a complete evaluation of these patients. Laparoscopic evidence serves as the gold standard for verifying peritoneal endometriosis and determining its stage, spread, and severity. A differential diagnosis of gastrointestinal pathologies, Müllerian anomalies, recurrent infections, and adenomyosis must be made. The treatment of this disease includes medical and surgical interventions, and a combination of both. ESRHE guidelines advise clinicians treating women with endometriosis to prescribe hormonal contraceptives or progestins to reduce endometriosis-associated pain. The use of gonadotropin hormone-releasing hormone agonists is acceptable in adolescents only if the patient with known endometriosis is refractory to other medical therapies or surgical treatments. The goals of medical therapy in the adolescent patient include symptomatic relief, suppression of disease progression, and protection of future fertility.